• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化跨膜传导调节因子(CFTR)突变的表型后果。

The phenotypic consequences of CFTR mutations.

作者信息

Rowntree Rebecca K, Harris Ann

机构信息

Paediatric Molecular Genetics, Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Oxford, OX3 9DS, UK.

出版信息

Ann Hum Genet. 2003 Sep;67(Pt 5):471-85. doi: 10.1046/j.1469-1809.2003.00028.x.

DOI:10.1046/j.1469-1809.2003.00028.x
PMID:12940920
Abstract

Cystic fibrosis is a common autosomal recessive disorder that primarily affects the epithelial cells in the intestine, respiratory system, pancreas, gall bladder and sweat glands. Over one thousand mutations have currently been identified in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene that are associated with CF disease. There have been many studies on the correlation of the CFTR genotype and CF disease phenotype; however, this relationship is still not well understood. A connection between CFTR genotype and disease manifested in the pancreas has been well described, but pulmonary disease appears to be highly variable even between individuals with the same genotype. This review describes the current classification of CFTR mutation classes and resulting CF disease phenotypes. Complex disease alleles and modifier genes are discussed along with alternative disorders, such as disseminated bronchiectasis and pancreatitis, which are also thought to result from CFTR mutations.

摘要

囊性纤维化是一种常见的常染色体隐性疾病,主要影响肠道、呼吸系统、胰腺、胆囊和汗腺中的上皮细胞。目前已在囊性纤维化跨膜传导调节因子(CFTR)基因中鉴定出一千多种与CF疾病相关的突变。关于CFTR基因型与CF疾病表型之间的相关性已有许多研究;然而,这种关系仍未得到充分理解。CFTR基因型与胰腺疾病表现之间的联系已有详尽描述,但即使在具有相同基因型的个体之间,肺部疾病似乎也具有高度变异性。本综述描述了CFTR突变类别的当前分类以及由此产生的CF疾病表型。还讨论了复杂疾病等位基因和修饰基因,以及其他疾病,如播散性支气管扩张和胰腺炎,这些疾病也被认为是由CFTR突变引起的。

相似文献

1
The phenotypic consequences of CFTR mutations.囊性纤维化跨膜传导调节因子(CFTR)突变的表型后果。
Ann Hum Genet. 2003 Sep;67(Pt 5):471-85. doi: 10.1046/j.1469-1809.2003.00028.x.
2
Genotype and phenotype in cystic fibrosis.囊性纤维化中的基因型与表型。
Respiration. 2000;67(2):117-33. doi: 10.1159/000029497.
3
Genetics of Cystic Fibrosis: Clinical Implications.囊性纤维化的遗传学:临床意义
Clin Chest Med. 2016 Mar;37(1):9-16. doi: 10.1016/j.ccm.2015.11.002. Epub 2015 Dec 24.
4
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.囊性纤维化跨膜电导调节因子(CFTR)基因突变与胰腺炎。
J Cyst Fibros. 2012 Sep;11(5):355-62. doi: 10.1016/j.jcf.2012.05.001. Epub 2012 Jun 2.
5
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症中囊性纤维化跨膜电导调节子通道功能障碍。
Am J Respir Crit Care Med. 2010 May 15;181(10):1078-84. doi: 10.1164/rccm.200909-1434OC. Epub 2010 Feb 18.
6
Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders.囊性纤维化及囊性纤维化跨膜传导调节因子相关疾病中的基因型与表型
Semin Respir Crit Care Med. 2015 Apr;36(2):180-93. doi: 10.1055/s-0035-1547318. Epub 2015 Mar 31.
7
CFTR gene mutations in adults with disseminated bronchiectasis.患有弥漫性支气管扩张症的成人中的囊性纤维化跨膜传导调节因子(CFTR)基因突变
Eur J Hum Genet. 1997 May-Jun;5(3):149-55.
8
Variant cystic fibrosis phenotypes in the absence of CFTR mutations.无CFTR基因突变时的囊性纤维化变异表型。
N Engl J Med. 2002 Aug 8;347(6):401-7. doi: 10.1056/NEJMoa011899.
9
[Cystic fibrosis modifying genes].[囊性纤维化修饰基因]
Pneumologie. 2005 Jun;59(6):395-404. doi: 10.1055/s-2004-830251.
10
Modifier genetics: cystic fibrosis.修饰基因学:囊性纤维化
Annu Rev Genomics Hum Genet. 2005;6:237-60. doi: 10.1146/annurev.genom.6.080604.162254.

引用本文的文献

1
Molecular mechanisms and pathological implications of unconventional protein secretion in human disease: from cellular stress to therapeutic targeting.人类疾病中非传统蛋白质分泌的分子机制及病理意义:从细胞应激到治疗靶点
Mol Biol Rep. 2025 Feb 15;52(1):236. doi: 10.1007/s11033-025-10316-6.
2
Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis.囊性纤维化婴儿肠道微生物群发育成熟持续延迟。
mBio. 2025 Mar 12;16(3):e0342024. doi: 10.1128/mbio.03420-24. Epub 2025 Feb 13.
3
Cystic Fibrosis: A Journey through Time and Hope.
囊性纤维化:穿越时间的希望之旅。
Int J Mol Sci. 2024 Sep 4;25(17):9599. doi: 10.3390/ijms25179599.
4
More evidence for widespread antagonistic pleiotropy in polymorphic disease alleles.多态性疾病等位基因中广泛存在拮抗性多效性的更多证据。
Front Genet. 2024 Jun 17;15:1404516. doi: 10.3389/fgene.2024.1404516. eCollection 2024.
5
A narrative review on the role of genetics in children with acute recurrent pancreatitis and chronic pancreatitis.关于遗传学在儿童急性复发性胰腺炎和慢性胰腺炎中作用的叙述性综述。
Pediatr Investig. 2023 Oct 21;7(4):268-276. doi: 10.1002/ped4.12404. eCollection 2023 Dec.
6
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
7
The landscape of tolerated genetic variation in humans and primates.人类和灵长类动物中可耐受遗传变异的景观。
Science. 2023 Jun 2;380(6648):eabn8153. doi: 10.1126/science.abn8197.
8
The landscape of tolerated genetic variation in humans and primates.人类和灵长类动物中可耐受的基因变异情况。
bioRxiv. 2023 May 2:2023.05.01.538953. doi: 10.1101/2023.05.01.538953.
9
Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies.囊性纤维化的分子靶点及单克隆抗体的治疗潜力
Saudi Pharm J. 2022 Dec;30(12):1736-1747. doi: 10.1016/j.jsps.2022.10.002. Epub 2022 Oct 8.
10
The Human Respiratory Microbiome: Current Understandings and Future Directions.人类呼吸微生物组:当前的认识和未来的方向。
Am J Respir Cell Mol Biol. 2023 Mar;68(3):245-255. doi: 10.1165/rcmb.2022-0208TR.